HOUSTON METHODIST THE WOODLANDS — History
CCN 670122 | 3-year financial timeline | COVID resilience: 86/100
🛡️ Public data only — no PHI permitted on this instance.
$536M
Latest Revenue (FY2022)
+23.8%
Revenue CAGR (3yr)
13.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $349M | $469M | $536M | +14.2% | +23.8% |
| Operating Expenses | $307M | $376M | $462M | +22.7% | +22.5% |
| Operating Margin | 12.0% | 19.9% | 13.9% | -30.0% | +7.5% |
| Net Income | $42M | $93M | $74M | -20.1% | +33.1% |
| Licensed Beds | 186 | 186 | 292 | +57.0% | +25.3% |
| Total Patient Days | 45,665 | 64,425 | 73,336 | +13.8% | +26.7% |
| Medicare Day % | 31% | 27% | 27% | -2.1% | -7.9% |
| Medicaid Day % | 9% | 8% | 8% | -0.7% | -7.1% |
COVID Impact & Recovery
Resilience Score: 86/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +53.4% ($349M → $536M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+23.8%
This Hospital
+7.6%
State Avg
Latest Margin
13.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $629M | 14.8% |
| FY2024 (proj) | $722M | 15.8% |
| FY2025 (proj) | $816M | 16.7% |